In contrast, DC-SIGN with AA at rs735240 have reduced DC-SIGN expression, which prevents the EBV from infecting DCs and epithelial cells, thus decreasing the NPC risk. The gene discussed is CD209; the disease is nasopharyngeal carcinoma.